Opt in or opt out: what is optimal for prenatal screening for HIV infection?
Walmsley
Sharon
S
University of Toronto, Toronto, Ont. sharon.walmsley@uhn.on.ca
D002170:Canada / Q000453:epidemiology; D005260:Female; D015658:HIV Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control / Q000706:statistics & numerical data; D008403:Mass Screening / Q000592:standards* / Q000706:statistics & numerical data; D018579:Patient Selection; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D011296:Prenatal Diagnosis / Q000592:standards* / Q000706:statistics & numerical data